Johnson & Johnson Medical Devices Companies announced Ethicon has launched a new global registry to collect and analyze real-world data on patients with soft tissue liver lesions ablated with the company’s Neuwave Microwave Ablation System. The company made the announcement at the annual meeting of the Society of Interventional Radiology (SIR 2019), March 23-28 in Austin, Texas.

Qaelum NV of Leuven, Belgium, and Toyo Corp. of Tokyo, Japan announced they have entered into a cooperation agreement for the distribution throughout Japan of Qaelum’s dose monitoring solution — Dose.

Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the Maryland Proton Treatment Center, presented publicly the first pre-clinical results of its research on ultra-high-dose rate cancer treatments with protons. Known as Flash therapy, it is a non-invasive therapy for cancer delivering high doses of radiation in ultra-high-speeds (less than 1 second) and represents the potential for a major breakthrough in the treatment of cancer. The preclinical Flash therapy results — presented at the American Association for Cancer Research (AACR) annual meeting, March 29-April 3 in Atlanta — showed reduced toxicity in healthy tissues and organs.

Digital pathology company Deep Lens Inc. announced the closing of a $14 million Series A financing that will further expand the company’s artificial intelligence (AI) and platform product development activities. Deep Lens is focused on AI-driven digital pathology for clinical trial recruitment at the time of diagnosis.

The Society of Interventional Radiology (SIR) presented its highest honor, the SIR Gold Medal, to Alan H. Matsumoto, M.D., FSIR; Daniel Picus, M.D., FSIR; and James B. Spies, M.D., MPH, FSIR, during its Annual Scientific Meeting, March 23-28 in Austin, Texas. These awards acknowledge distinguished and extraordinary service to SIR or to the discipline of interventional radiology.